Carestream Strike PACS Gold with Cheshire and Merseyside NHS Consortium

CarestreamCarestream Team GB has struck Gold and been awarded preferred bidder status for the supply of PACS to the Cheshire and Merseyside NHS Consortium.

As existing contracts for PACS and RIS systems, delivered through the NPfIT Programme expired, Informatics Merseyside facilitated a consortium of eleven independent NHS Trusts to work together to source the provision of replacement PACS systems. Members of the Consortium, who operate fifteen sites across the Cheshire and Merseyside area, are using the opportunity to deliver improvements in patient care through more integrated data sharing and workflows. Hospitals within the Consortium perform a total of 1.35 million radiology examinations each year.

Subject to successful conclusion of contracts, there will be eleven individual PACS agreements with each of the participating Trusts for five year Managed Service Contracts with the option to extend for another 5 years. Installation will commence in early 2013.

Commenting on the award of preferred bidder status, Managing Director of Carestream UK, Charlie McCaffrey, said: "We have a great reputation for service in the North West of England and this is our chance to extend the high quality support that our customers expect to this PACS implementation."

Related news articles:

About Carestream Health
Carestream Health is a worldwide provider of dental and medical imaging systems and healthcare IT solutions; molecular imaging systems for life science research and drug discovery/development; X-ray film and digital X-ray systems for non-destructive testing; and advanced materials for the precision films and electronics markets.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...